Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
TERN
Shares outstanding
84,519,683 shares
Disclosed Ownership
3,465,307 shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 18:25:45 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 4.1% ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") (TERN) on 31 Dec 2024."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") (TERN).
  • Disclosed ownership: 4.1%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 18:25.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 3.9% 3,267,779 0 3,267,779 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 3.9% 3,267,779 0 3,267,779 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 3.9% 3,267,779 0 3,267,779 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.2% 197,528 0 197,528 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0.2% 197,528 0 197,528 /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0.2% 197,528 0 197,528 /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 4.1% 3,465,307 0 3,465,307 /s/ Seth Levy Seth Levy, attorney-in-fact*